Laserfiche WebLink
however, objective evidence exists establishing reasonable suspicion to believe an Employee's <br />work performance is impaired due to drug or alcohol abuse, the Employer will require the <br />Employee to undergo a medical test consistent with the conditions as set forth in this Policy. <br />33.4 SAMPLE COLLECTION <br />The collection and testing of the samples shall be performed only by a laboratory and by a <br />physician or health care professional qualified and authorized to administer and determine the <br />meaning of any test results. The laboratory performing the test shall be one that is certified by the <br />National Institute of Drug Abuse (NIDA). The laboratory chosen must be agreed to between the <br />Associarion and the Employer. The laboratory used shall also be one whose procedures are <br />periodically tested by NIDA where they analyze unknown samples sent to an independent party. <br />The results of Employee tests shall be made available to the Medical Review Physician. <br />Collection of blood or urine samples shall be conducted in a manner which ptovides the highest <br />degree of security for the sample and freedom from adulteration. Recognized strict chain of <br />custody procedures must be followed for all samples as set by NIDA. The Association and the <br />Employer agree that security of the biological urine and blood samples is absolutely necessary, <br />therefore, the Employer agrees that if the security of the sample is compromised in any way, any <br />posirive test shall be invalid and may not be used for any purpose. Blood or urine samples will be <br />submitted as per NIDA Standards. Employees have the right for Association or legal counsel <br />representatives to be present during the submission of the sample. <br />A split sample shall be reserved in all cases for an independent analysis in the event of a positive <br />test result. All samples must be stored in a scientific acceptable preserved maqner as established <br />by NIDA. All positive confirmed samples and related paperwork must be retained by the <br />laboratory for at least six months or for the duration of any grievance disciplinary action or legal <br />proceedings, whichever is longer. At the conclusion of this period, the paperwork and specimen <br />shall be destroyed. Tests shall be conducted in a manner to ensure that an Employee's legal drug <br />use and diet does not affect the test results. <br />33.5 DRUG TESTING <br />The laboratory shall test only for substances and within the limits for the initial and confirmation <br />test as provided within NIDA standards. The initial test shall use an immunoassay which meets <br />the requirements of the Food and Diug Administrarion for comrnercial dislribution. The following <br />initial cutoff levels shall be used when screening specimens to determine whether they aze <br />negarive for these five drugs or classes of drugs: <br />Marijuana metabolites 50 ng/ml <br />43 <br />